So far, only two duplicate FGFR1 M456V missense mutations have been detected in tissue samples from SCLC patients 5,17, with frequency ranging from 0.9% to 3.4%, but whether there are biological roles remain unclear and need to be further verified. This evidence concerns the gene FGFR1 and small cell lung carcinoma.